Veterinary Renal Disease Market Size, Share, Trends & Forecast, 2026–2034
REPORT DETAILS
Veterinary Renal Disease Market Summary
The market is anticipated to grow from USD 17.79 billion in 2025 to USD 29.65 billion by 2034, exhibiting the CAGR of 5.90% during the forecast period.
Market Statistics
Veterinary Renal Disease Market Key Takeaways
- In 2025, North America had the largest market share of 42.4%. High pet ownership and good veterinary care helped the region to stay ahead.
- Asia Pacific is expected to grow at a CAGR of 10.7% during 2026–2034. More people are keeping pets, and veterinary care is improving across the region.
- By 2025, the treatment segment accounted for 67.8% of the market. The growing need for long-term care is driving the demand.
- The feline segment is expected to grow at a CAGR of 11.2% during the forecast period 2026–2034. Growth is being supported by more older cats and better awareness of kidney health.
- Oral administration captured 63.5% of the market in 2025. It is easy to use and is a common choice for long-term treatment.
- Diagnosis is expected to grow at a CAGR of 11.5% during 2026–2034. More clinics are adopting early testing to detect kidney disease earlier.
Note: Figures and projections outlined in this report are the result of Polaris Market Research’s proprietary analytical processes, grounded in the latest available datasets and market observations.
What Is Veterinary Renal Disease? CKD, AKI, Renal Failure & Renal-Care Market Scope
Veterinary renal disease refers to kidney disorders that affect both companion and livestock animals. These conditions reduce kidney function and require timely diagnosis and treatment. The market includes diagnostic tools, medicines, therapeutic diets, supplements, and monitoring solutions for kidney disease. These products contribute to the improvement of animal health and quality of life.
AI Impact on Veterinary Renal Disease Market
- AI helps analyze urine samples faster. It makes easier to detect kidney disease at an early stage.
- AI monitors a pet's health over time. This helps identify signs of kidney disease before the condition worsens.
- AI can read test and medical images faster, allowing vets to quickly and correctly diagnose conditions.
- Based on the pet’s medical history and current health AI helps to plan personalized treatments.
Source: Polaris Market Research Analysis
To Understand More About this Research: Download Sample Report
How Is Veterinary Kidney Disease Diagnosed and Managed? Blood Tests, Urinalysis, Biomarkers, Imaging, Diets & Therapy
Veterinary renal disease management begins when a pet begins to show signs of kidney problems. Typical signs include increased water consumption, decreased appetite, weight loss or lack of energy. Blood tests, urine tests, and sometimes imaging are used to determine the kidney function. The results of the tests are used to determine the stage of the disease. Then a treatment plan is developed. This can include medications, a special renal diet, fluids, or supportive care. To monitor the pet’s condition frequent blood and urine tests are used. Follow-up visits allow the veterinarian to alter treatment if necessary. This helps to slow the progression of the disease and improve the pet’s quality of life.
Veterinary Renal Disease Market Trends & Clinical Context
The veterinary renal disease market share experiences growth driven by the demand for renal therapeutics. With rising instances of renal diseases in companion animals like chronic kidney disease (CKD) and urinary tract infections, there's a need for tailored treatment options. The expanding pet population, particularly aging animals, contributes to this demand. Advances in veterinary medicine have led to novel renal therapeutics, such as medications, supplements, and therapeutic diets, aiming to support renal function and enhance the quality of life for affected animals.
In addition, companies operating in the market are introducing new products to expand market reach and strengthen their presence.
- For instance, in June 2023, IDEXX Laboratories, Inc. unveiled the introduction of the veterinary diagnostic examination aimed at identifying kidney damage in felines and canines. The IDEXX Cystatin B Test is set to be integrated into test arrays designed for evaluating renal well-being.
Awareness and education are pivotal drivers in the growth of the Kidney Disease market. As pet owners gain knowledge about preventive healthcare, they become proactive in seeking veterinary care, leading to early detection and intervention. Veterinary professionals play a crucial role in educating owners about risk factors, symptoms, and management strategies for renal diseases in animals. Advanced diagnostic technologies enable accurate detection, reinforcing the importance of awareness and education. Initiatives by veterinary organizations and animal welfare groups also contribute to raising awareness about renal health.
Veterinary CKD vs AKI in Dogs and Cats: Progression, Diagnosis, Treatment & Prognosis
| Factor | Chronic Kidney Disease (CKD) | Acute Kidney Injury (AKI) |
| Progression | Gradual progression | Sudden development |
| Cause | Aging and chronic health conditions | Toxins, infections, or trauma |
| Treatment | Long-term disease management | Immediate medical intervention |
| Prognosis | Can be managed with ongoing care | Varies based on severity and treatment timing |
Source: Polaris Market Research Analysis
Market Dynamics
Increasing pet ownership is projected to spur the product demand
The veterinary renal disease market report is burgeoning due to rising pet ownership worldwide. As more individuals embrace companion animals, instances of renal issues among pets increase. Factors like aging populations, genetic predispositions, and dietary habits contribute to this rise. Pet owners' heightened awareness of preventive healthcare prompts them to seek timely veterinary interventions, fostering early detection and treatment of renal diseases. Moreover, novel therapeutic approaches such as dietary management and medications offer diverse treatment options.
Advancements in veterinary medicine are expected to drive End Stage Renal Disease market growth
Advancements in veterinary medicine are fueling growth in the veterinary renal disease market growth. Advancements in the market industry encompass innovations improving diagnostics, treatments, and management strategies for companion animals. These include advanced imaging techniques like ultrasound and CT scans for early detection of renal abnormalities. Novel medications, supplements, and therapeutic diets support renal function and manage symptoms effectively. Additionally, there's a focus on preventive care and client education, promoting awareness of renal health among pet owners.
Source: Polaris Market Research Analysis
Growing Burden of Kidney Disease in Dogs and Cats
Dogs and cats represent the largest proportion of kidney disease cases. Chronic kidney disease occurs in about 1-3% of cats according to the International Renal Interest Society (IRIS), and the percentage increases in older cats. As pets live longer lives, kidney problems are becoming more common. Improvements in diagnostic tools and awareness among pet owners also mean earlier detection and treatment (Source: www.mdpi.com).
Role in Veterinary Healthcare
Renal disease management is an important part of veterinary healthcare. In aging dogs and cats kidney disorders are common and often require long-term care. Regular monitoring, early diagnosis and prompt treatment help slow the disease and reduce complications. To manage this condition blood tests, urine tests, medicines and special renal diets are common ways. The demand for veterinary renal care is being driven by the growing pet ownership and increased awareness of pet health.
Industry Challenges
High cost of treatment is likely to impede the market growth
The veterinary renal disease market trends face growth limitations due to the high cost of treatment. Expenses for diagnostics, medications, and specialized care are high, particularly for chronic conditions like chronic kidney disease (CKD). Financial constraints often hinder pet owners from pursuing comprehensive treatment, leading to delayed interventions and compromised health outcomes for their animals. Additionally, the high costs may discourage preventive care and routine check-ups, accelerating the progression of renal diseases. To address this challenge, affordable treatment options, and financial assistance programs are needed to make veterinary care more accessible.
Veterinary Renal Disease Market Segmentation Analysis
The veterinary renal disease market analysis is primarily segmented based on type, animal type, route of administration, and region.
| By Type | By Animal Type | By Route of Administration | By Region |
|
|
|
|
Source: Polaris Market Research Analysis
Veterinary Renal Disease Market by Type
By 2025, the treatment segment accounted for 67.8% of the market.Veterinary renal disease treatment involves a comprehensive approach tailored to manage symptoms and preserve renal function in companion animals. Strategies include dietary management with prescription renal diets, medication to address symptoms like hypertension and electrolyte imbalances, and fluid therapy to maintain hydration and support kidney function. Treating underlying conditions contributing to renal disease is crucial. Regular monitoring via blood tests and imaging helps assess disease progression and adjust treatment. In advanced cases, supportive measures like dialysis or kidney transplantation are required.
Veterinary Renal Disease Market by Animal Type
The feline segment is expected to grow at a CAGR of 11.2% during the forecast period 2026–2034. Cats are inherently prone to various renal ailments like chronic kidney disease, urinary tract infections, and kidney stones. With the escalating global cat ownership rates, there's a heightened demand for veterinary services, diagnostics, and treatments specific to feline renal conditions. Additionally, improved healthcare and nutrition have prolonged cats' lives, leading to a higher prevalence of age-related renal issues. Furthermore, the strong emotional bond between cat owners and their pets encourages proactive healthcare-seeking, driving further revenue growth in this segment.
Veterinary Renal Disease Treatment by Route
Oral administration captured 63.5% of the market in 2025. Oral medications are convenient and easy to administer to animals, ensuring better compliance with treatment regimens. Many therapeutic options for renal conditions are available in oral formulations, providing veterinarians with effective treatment choices. Additionally, oral medications offer flexibility in adjusting dosages and treatment regimens based on individual animal responses. The convenience, efficacy, and availability of oral medications make this segment a significant contributor to revenue in the veterinary renal disease market study.
Real-World Examples of Veterinary Renal Disease Management
| Application | Real-World Example |
| Chronic kidney disease management | An older cat is given a renal diet, medicines, and regular check-ups to manage CKD. |
| Kidney function monitoring | A senior dog has routine blood and urine tests to monitor kidney health. |
| Acute kidney injury treatment | A dog receives emergency treatment after ingesting a toxic substance that damages the kidneys. |
| Therapeutic diet programs | A pet with kidney disease is switched to a prescription renal diet to support kidney function. |
| Long-term nephritis management | A pet with nephritis receives medicines and regular veterinary follow-up to control the condition. |
| Renal biomarker monitoring | A veterinary hospital uses blood tests such as creatinine and SDMA to monitor kidney function over time. |
Source: Polaris Market Research Analysis
Source: Polaris Market Research Analysis
Veterinary Renal Disease Market by Region
In 2025, North America had the largest market share of 42.4%. The North American veterinary renal disease market analysis offers a comprehensive range of products and services for diagnosing, treating, and managing renal conditions in companion animals. With a growing pet population and heightened awareness of pet health, demand for veterinary renal care solutions is increasing across the region. This market includes advanced diagnostic tools like imaging modalities and laboratory tests alongside a variety of treatment options such as medications and therapeutic diets. Technological advancements in veterinary medicine drive innovation, leading to improved diagnostic accuracy and treatment outcomes. The competitive landscape sees key players expanding their product portfolios to meet the evolving needs of veterinarians and pet owners.
Asia Pacific is expected to grow at a CAGR of 10.7% during 2026–2034. In the Asia-Pacific region, the market share is propelled by increasing pet ownership rates and rising affluence. With urbanization and disposable incomes on the rise, there's a growing awareness of pet health. Adoption of Westernized lifestyles leads to greater acceptance of advanced veterinary practices. Emerging markets like China and India offer significant growth potential.
Source: Polaris Market Research Analysis
Key Market Players & Competitive Insights
The market size comprises a diverse array of players, and the expected entry of new contenders is poised to intensify competitive dynamics. Prominent leaders in the market continuously enhance their technologies, striving to maintain a competitive advantage by emphasizing efficiency, reliability, and safety. These entities prioritize strategic endeavors, including forming alliances, improving product portfolios, and participating in collaborative ventures. Their primary goal is to outperform others in the industry, ultimately securing a significant veterinary renal disease market share.
Veterinary Renal Disease Competitive Landscape & Leading Renal-Care Companies
- Bayer Animal Health
- Boehringer Ingelheim Animal Health
- Ceva Santé Animale
- Dechra Pharmaceuticals
- Elanco Animal Health
- Hills Pet Nutrition
- IDEXX Laboratories
- Mars, Inc.
- Neogen Corporation
- Nestle Purina PetCare
- Nutramax Laboratories Veterinary Sciences, Inc.
- Phibro Animal Health Corporation
- Roquette Frères
- VetPharma
- Zoetis
Challenges in the Veterinary Renal Disease Market
The veterinary renal disease market faces several challenges that can limit its growth. For many pet owners high treatment costs make long-term care difficult. Kidney disease is often diagnosed at a later stage, reducing treatment options. Limited availability of veterinary specialists also impacts access to care, especially in rural areas. Regulatory approval for new treatments can also take time and delay product launches. As some pets may not easily accept medicines or special renal diets treatment compliance can also be a challenge.
Recent Developments
- July 2026: Varenzin from Elanco Animal Health was launched in the UK for cats with anemia associated with chronic kidney disease (CKD). The once daily oral treatment offers veterinarians another option to treat cats with CKD-associated anemia. (Source: www.vettimes.com)
- May 2026: IDEXX Laboratories added the SDMA renal biomarker to its Catalyst chemistry profiles. This helps veterinarians detect kidney disease in dogs and cats earlier during routine health check-ups. (Source: ir.idexx.com)
Veterinary Renal Disease Market Future Outlook: Early Biomarkers, AI, Renal Nutrition & Targeted CKD Therapies
The veterinary renal disease market is expected to grow steadily in the coming years. Increasing pet ownership and the growing number of aging animals will continue to drive demand. Improved diagnostic tools, AI-based technologies and biomarker testing will help with earlier diagnosis and better treatment. Rising investment in companion animal healthcare and expanding veterinary services especially in Asia Pacific will provide new growth opportunities.
Veterinary Renal Disease Market Report Coverage, Scope & Competitive Analysis
The veterinary renal disease market report emphasizes on key regions across the globe to provide better understanding of the product to the users. Also, the report provides market insights into recent developments, trends and analyzes the technologies that are gaining traction around the globe. Furthermore, the report covers in-depth qualitative analysis pertaining to various paradigm shifts associated with the transformation of these solutions.
The report provides detailed analysis of the market while focusing on various key aspects such as competitive analysis, types, animal types, routes of administration, and their futuristic growth opportunities.
Veterinary Renal Disease Market Report Scope
| Report Attributes | Details |
| Market size value in 2025 | USD 17.79 billion |
| Market size value in 2026 | USD 18.8 billion |
| Revenue forecast in 2034 | USD 29.65 billion |
| CAGR | 5.90% from 2026 – 2034 |
| Base year | 2025 |
| Historical data | 2021 – 2024 |
| Forecast period | 2026 – 2034 |
| Quantitative units | Revenue in USD billion and CAGR from 2026 to 2034 |
| Segments covered |
|
| Regional scope |
|
| Competitive Landscape |
|
| Report Format |
|
| Customization | Report customization as per your requirements with respect to countries, region and segmentation. |
Source: Polaris Market Research Analysis
Veterinary Renal Disease Market FAQ's
The global Veterinary Renal Disease market size is expected to reach USD 29.65 billion by 2034
Bayer Animal Health, Boehringer Ingelheim Animal Health, Ceva Santé Animale, Elanco Animal Health, IDEXX Laboratories, Nestle Purina PetCare, Nutramax Laboratories Veterinary Sciences, Inc are the top market players in the market.
North America dominated the Veterinary Renal Disease Market with a 42.4% share, driven by growing pet healthcare awareness and advanced veterinary care.
Veterinary Renal Disease Market exhibiting the CAGR of 5.90% during the forecast period.
The treatment segment accounted for the largest market share of 67.8%, driven by the growing prevalence of veterinary renal diseases.
Veterinary Renal Disease is a disease of the kidney in animals. It affects the filtering of blood and waste removal by the kidneys.
Older pets are more prone to developing chronic kidney disease. Infections, other health issues and genetics can also be responsible.
The veterinarian checks the pet with blood and urine tests. An ultrasound may also be done if needed.
Treatment can involve medications, special kidney diets and fluid therapy. The treatment will be based on the pet’s condition and stage of disease.
Download Sample Report of Veterinary Renal Disease Market
Please fill out the form to request a customized copy of the research report.
